|
|
||||||||
1 Associate Surgeon, Head and Neck Service, Department of Surgery, The University of Texas System Cancer Center, M. D.
Anderson Hospital and Tumor Institute, Houston, Texas.
2 Assistant Surgeon, Head and Neck Service, Department of Surgery, The University of Texas System Cancer Center, M. D.
Anderson Hospital and Tumor Institute, Houston, Texas.
3 Associate Pathologist, Department of Pathology, The University of Texas System Cancer Center, M. D. Anderson Hospital and
Tumor Institute, Houston, Texas.
4 Fellow in Radiotherapy, Department of Radiotherapy, The University of Texas System Cancer Center, M. D. Anderson Hospital
and Tumor Institute, Houston, Texas.
5 Chief, Head and Neck Service, Department of Surgery, The University of Texas System Cancer Center, M. D. Anderson Hospital
and Tumor Institute, Houston, Texas.
6 Head, Department of Radiotherapy, The University of Texas System Cancer Center, M. D. Anderson Hospital and Tumor
Institute, Houston, Texas.
A 7 year follow-up of 120 patients with malignant parotid cancers reveals parotidectomy to be an adequate procedure for low-grade, nonaggressive lesions.
The addition of radiation therapy postoperatively will improve local and regional control of high-grade, aggressive lesions. Postoperative radiation therapy may also make the removal of the facial nerve unnecessary in certain clinical presentations.
This article has been cited by other articles:
![]() |
J. Fordice, C. Kershaw, A. El-Naggar, and H. Goepfert Adenoid Cystic Carcinoma of the Head and Neck: Predictors of Morbidity and Mortality Arch Otolaryngol Head Neck Surg, February 1, 1999; 125(2): 149 - 152. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |